A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies

Immune checkpoint inhibitor (ICI) therapies can improve clinical outcomes for patients with solid tumors, but relatively few patients respond. Because ICI therapies support an adaptive immune response, patients with an active tumor microenvironment (TME) may be more likely to respond, and thus bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Tyler J., Ring, Brian Z., Seitz, Robert S., Hout, David R., Schweitzer, Brock L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970145/
https://www.ncbi.nlm.nih.gov/pubmed/33748492
http://dx.doi.org/10.1016/j.heliyon.2021.e06438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970145/
https://www.ncbi.nlm.nih.gov/pubmed/33748492
http://dx.doi.org/10.1016/j.heliyon.2021.e06438

Ejemplares similares